Gut check: could your microbiome make immunotherapy work better?
NCT ID NCT07236983
First seen Nov 19, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study looks at how the bacteria in your gut might influence how well immunotherapy works for solid tumors. Researchers will collect stool and blood samples from 70 cancer patients starting immunotherapy to track changes in gut bacteria and immune markers. The goal is to understand these interactions, not to test a new treatment, which may help improve cancer care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR CANCER TREATMENT WITH IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Oncologia
Pavia, Pavia, 27100, Italy
Conditions
Explore the condition pages connected to this study.